Future studies incorporating ER antagonists, along with detailed characterization of intracranial androgen metabolism, will be critical in further delineating the specific pathways through which androgens drive reproductive dysfunction in PCOS. The gene discussed is ESR1; the disease is polycystic ovary syndrome.